Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer

Affiliations

• ¹ Cancer Dynamics Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
• ² Cancer Dynamics Laboratory, The Francis Crick Institute, London, NW1 1AT, UK; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
• ³ Tuberculosis Laboratory, The Francis Crick Institute, London, NW1 1AT, UK; Wellcome Center for Infectious Disease Research in Africa, University of Cape Town, Observatory 7925, Republic of South Africa.
• ⁴ High Throughput Screening Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
• ⁵ Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
• ⁶ Worldwide Influenza Centre, The Francis Crick Institute, London, NW1 1AT, UK.
• ⁷ Structural Biology STP, The Francis Crick Institute, London NW1 1AT, UK.
• ⁸ Tuberculosis Laboratory, The Francis Crick Institute, London, NW1 1AT, UK; University College London Hospitals NHS Foundation Trust Biomedical Research Centre, London, WC1E 6BT, UK.
• ⁹ Cell Biology of Infection Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
• ¹⁰ Safety, Health & Sustainability, The Francis Crick Institute, London, NW1 1AT, UK.
• ¹¹ Scientific Computing Scientific Technology Platform, The Francis Crick Institute, London, NW1 1AT, UK.
• ¹² Metabolomics Scientific Technology Platform, The Francis Crick Institute, London, NW1 1AT, UK.
• ¹³ Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK.
• ¹⁴ Department of Pathology, The Royal Marsden NHS Foundation Trust, London, NW1 1AT, UK; Translational Cancer Biochemistry Laboratory, The Institute of Cancer Research, London, SW7 3RP, UK.
• ¹⁵ Translational Cancer Biochemistry Laboratory, The Institute of Cancer Research, London, SW7 3RP, UK.
• ¹⁶ Lung Unit, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK; Acute Oncology Service, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
• ¹⁷ Anaesthetics, Perioperative Medicine, and Pain Department, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
• ¹⁸ Clincal Oncology Unit, The Royal Marsden NHS Foundation Trust, London, NW1 1AT, UK.
• ¹⁹ University College London Hospitals NHS Foundation Trust Biomedical Research Centre, London, WC1E 6BT, UK; Division of Medicine, University College London, London NW1 2PG, UK.
• ²⁰ Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, NW1 1AT, UK; University College London Cancer Institute, London WC1E 6DD, UK.
• ²¹ Neurodegeneration Biology Laboratory, The Francis Crick Institute, London, NW1 1AT, UK; UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK.
• ²² Structural Biology of Disease Processes Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
• ²³ RNA Virus Replication Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
• ²⁴ Retroviral Immunology Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
• ²⁵ Haemato-oncology Unit, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
• ²⁶ Acute Oncology Service, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
• ²⁷ Tuberculosis Laboratory, The Francis Crick Institute, London, NW1 1AT, UK; Wellcome Center for Infectious Disease Research in Africa, University of Cape Town, Observatory 7925, Republic of South Africa; Department of Infectious Disease, Imperial College London, London, W12 0NN, UK.
• ²⁸ Cancer Dynamics Laboratory, The Francis Crick Institute, London, NW1 1AT, UK; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK. Electronic address: [email protected].